Ekso Bionics Holdings Inc
(EKSO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,901 | -29,122 | -20,144 | -13,809 | -8,302 |
| Depreciation Amortization | 471 | 1,927 | 1,449 | 955 | 490 |
| Accounts receivable | -798 | -1,085 | -488 | -382 | 532 |
| Accounts payable and accrued liabilities | 1,011 | 77 | -750 | 328 | 988 |
| Other Working Capital | 527 | -3,577 | -4,461 | -1,797 | 117 |
| Other Operating Activity | -55 | 554 | -1,188 | -2,154 | -1,079 |
| Operating Cash Flow | $-6,745 | $-31,226 | $-25,582 | $-16,859 | $-7,254 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -31 | -456 | -353 | -248 | -138 |
| Investing Cash Flow | $-31 | $-456 | $-353 | $-248 | $-138 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -399 | -54 | -46 | -38 | -22 |
| Common Stock Issued | 0 | 42,622 | 42,505 | 10,961 | 24 |
| Financing Cash Flow | $-399 | $42,568 | $42,459 | $10,923 | $2 |
| Exchange Rate Effect | -66 | 81 | 69 | 39 | -30 |
| Beginning Cash Position | 27,813 | 16,846 | 16,846 | 16,846 | 16,846 |
| End Cash Position | 20,572 | 27,813 | 33,439 | 10,701 | 9,426 |
| Net Cash Flow | $-7,241 | $10,967 | $16,593 | $-6,145 | $-7,420 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,745 | -31,226 | -25,582 | -16,859 | -7,254 |
| Capital Expenditure | -31 | -456 | -353 | -248 | -138 |
| Free Cash Flow | -6,776 | -31,682 | -25,935 | -17,107 | -7,392 |